ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia
Cancer
◽
10.1002/cncr.32657
◽
2019
◽
Vol 126
(6)
◽
pp. 1264-1273
◽
Cited By ~ 7
Author(s):
Rupa Narayan
◽
Traci M. Blonquist
◽
Ashkan Emadi
◽
Robert P. Hasserjian
◽
Meghan Burke
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Induction Chemotherapy
◽
Myeloid Leukemia
◽
Phase 1
◽
Brentuximab Vedotin
◽
Antibody Drug Conjugate
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
◽
Antibody Drug
Download Full-text
Related Documents
Cited By
References
Randomized phase 1 study of sequential (“primed”) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
Leukemia & Lymphoma
◽
10.1080/10428194.2020.1728754
◽
2020
◽
Vol 61
(7)
◽
pp. 1728-1731
Author(s):
Raffaele Palmieri
◽
Sarah A. Buckley
◽
Megan Othus
◽
Anna B. Halpern
◽
Mary-Elizabeth M. Percival
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
High Grade
◽
Newly Diagnosed
◽
Phase 1 Study
◽
Myeloid Neoplasm
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Abstract A106: A phase 1 study of ENMD‐2076 in patients with relapsed or refractory acute myeloid leukemia (AML)
10.1158/1535-7163.targ-09-a106
◽
2009
◽
Cited By ~ 2
Author(s):
Karen W. Yee
◽
Joseph Brandwein
◽
Mark D. Minden
◽
Deborah Sanfelice
◽
Sue Chow
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.7044
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 7044-7044
◽
Cited By ~ 11
Author(s):
Jorge E. Cortes
◽
Stefan Faderl
◽
John Pagel
◽
Chul Won Jung
◽
Sung-Soo Yoon
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Phase 1
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Abstract DDT02-04: SGN-CD33A: Preclinical and phase 1 interim clinical trial results of a CD33-directed PBD dimer antibody-drug conjugate for the treatment of acute myeloid leukemia (AML)
10.1158/1538-7445.am2015-ddt02-04
◽
2015
◽
Cited By ~ 1
Author(s):
Dana A. Kennedy
◽
Stephen C. Alley
◽
Baiteng Zhao
◽
Eric J. Feldman
◽
Megan O'Meara
◽
...
Keyword(s):
Clinical Trial
◽
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Antibody Drug Conjugate
◽
Drug Conjugate
◽
Clinical Trial Results
◽
Acute Myeloid
◽
Antibody Drug
Download Full-text
Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study
Cancer Science
◽
10.1111/cas.13749
◽
2018
◽
Vol 109
(10)
◽
pp. 3235-3244
◽
Cited By ~ 23
Author(s):
Kensuke Usuki
◽
Toru Sakura
◽
Yukio Kobayashi
◽
Toshihiro Miyamoto
◽
Hiroatsu Iida
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Japanese Patients
◽
Clinical Profile
◽
Open Label
◽
Phase 1 Study
◽
Open Label Phase
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia
Cancer
◽
10.1002/cncr.33590
◽
2021
◽
Author(s):
Gautam Borthakur
◽
Olatoyosi Odenike
◽
Ibrahim Aldoss
◽
David A. Rizzieri
◽
Thomas Prebet
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study
International Journal of Hematology
◽
10.1007/s12185-019-02709-8
◽
2019
◽
Vol 110
(6)
◽
pp. 654-664
◽
Cited By ~ 2
Author(s):
Kensuke Usuki
◽
Hiroshi Handa
◽
Ilseung Choi
◽
Takahiro Yamauchi
◽
Hiroatsu Iida
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Japanese Patients
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
Annals of Hematology
◽
10.1007/s00277-021-04734-2
◽
2022
◽
Author(s):
Amer M. Zeidan
◽
Daniel J. DeAngelo
◽
Jeanne Palmer
◽
Christopher S. Seet
◽
Martin S. Tallman
◽
...
Keyword(s):
Monoclonal Antibody
◽
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndromes
◽
Myeloid Leukemia
◽
Phase 1
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/j.clml.2018.07.057
◽
2018
◽
Vol 18
◽
pp. S204-S205
◽
Cited By ~ 1
Author(s):
Courtney D. DiNardo
◽
Eytan M. Stein
◽
Stéphane de Botton
◽
Gail J. Roboz
◽
Jessica K. Altman
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Mutant Idh1
◽
Acute Myeloid
Download Full-text
24 / Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study
10.26226/morressier.5b3b802cb1b87b000eced98e
◽
2018
◽
Cited By ~ 1
Author(s):
DiNardo Courtney D
Keyword(s):
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Phase 1
◽
Phase 1 Study
◽
Refractory Acute Myeloid Leukemia
◽
Mutant Idh1
◽
Acute Myeloid
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close